Koczkodaj, D.; Zmorzyński, S.; Grygalewicz, B.; Pieńkowska-Grela, B.; Styk, W.; Popek-Marciniec, S.; Filip, A.A.
WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients. J. Clin. Med. 2022, 11, 1873.
https://doi.org/10.3390/jcm11071873
AMA Style
Koczkodaj D, Zmorzyński S, Grygalewicz B, Pieńkowska-Grela B, Styk W, Popek-Marciniec S, Filip AA.
WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients. Journal of Clinical Medicine. 2022; 11(7):1873.
https://doi.org/10.3390/jcm11071873
Chicago/Turabian Style
Koczkodaj, Dorota, Szymon Zmorzyński, Beata Grygalewicz, Barbara Pieńkowska-Grela, Wojciech Styk, Sylwia Popek-Marciniec, and Agata Anna Filip.
2022. "WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients" Journal of Clinical Medicine 11, no. 7: 1873.
https://doi.org/10.3390/jcm11071873
APA Style
Koczkodaj, D., Zmorzyński, S., Grygalewicz, B., Pieńkowska-Grela, B., Styk, W., Popek-Marciniec, S., & Filip, A. A.
(2022). WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients. Journal of Clinical Medicine, 11(7), 1873.
https://doi.org/10.3390/jcm11071873
